Evidence map›Paper›PMID 30519378›Full record

ArticleThe Journal of clinical and aesthetic dermatology2018

Detection of Angiotensin II and AT

Feizollah Niazi, Seyed Hassan Hooshyar, Keshvad Hedayatyanfard, Seyed Ali Ziai, Farideh Doroodgar, Sana Niazi, Behnam Habibi, Ali Asadirad

Open access · greenAbstract read

PubMed Full text at PMC

In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it

0cells of the map it votes in

11citing papers in PubMed

0.9field-weighted citation impact, top 22% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

Efficacy of Topical Losartan in Management of Mammoplasty and Abdominoplasty Scars: A Randomized, Double-Blind Clinical Trial.Aesthetic plastic surgery · 2022
Trial
A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs.Chinese medicine · 2025
Article
Losartan in Situ Forming Gel as a New Treatment for Hypertrophic Scars.Aesthetic plastic surgery · 2025
Article
A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol.Trials · 2024
Article
Evidence of a causal relationship between blood pressure and pathological scars: a bidirectional Mendelian randomization study.Frontiers in medicine · 2024
Article
Future Directions About Keloid Scars Based on Pathogenesis and Therapies.Clinical, cosmetic and investigational dermatology · 2024
Review
Potential use of angiotensin receptor blockers in skin pathologies.Iranian journal of basic medical sciences · 2023
Review
Emerging and Novel Therapies for Keloids: A compendious review.Sultan Qaboos University medical journal · 2021
Review
Aliskiren Attenuates the Inflammatory Response and Wound Healing Process in Diabetic Mice With Periodontal Disease.Frontiers in pharmacology · 2019
Article
Keloids: Current and emerging therapies.Scars, burns & healing
Review
Exploring the Molecular Underpinnings of Skin Regeneration and Wound Healing: The Role of Renin Angiotensin.Avicenna journal of medical biotechnology
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Feizollah NiaziDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Seyed Hassan HooshyarDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Keshvad HedayatyanfardDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Seyed Ali ZiaiDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Farideh DoroodgarDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Sana NiaziDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Behnam HabibiDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Ali AsadiradDrs. Niazi, Hooshyar, Doroodgar, and Niazi are with the Department of Plastic and Reconstructive Surgery at Modarres Hospital School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran.

Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin IIAT1ELISAhypertrophic scarkeloid

Identifiers

PMID30519378

PMCPMC6239163

OpenAlexW3009456715

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.